Emergence of resistance to fluoroquinolones and third-generation cephalosporins in Shigella flexneri subserotype 1c isolates from China  by Qiu, S. et al.
Emergence of resistance to
fluoroquinolones and third-generation
cephalosporins in Shigella flexneri
subserotype 1c isolates from China
S. Qiu1*, X. Xu2*, Y. Wang1*, G. Yang1*, Z. Wang1*,
H. Wang3*, L. Zhang3*, N. Liu1, C. Chen1, W. Liu1,
J. Li1, W. Su1, L. Jia1, L. Wang1, H. Jin2, P. Keim4, Z. Yuan2,
L. Huang1 and H. Song1
1) Institute of Disease Control and Prevention, Academy of Military
Medical Sciences, Beijing, China, 2) Shanghai Municipal Center for
Disease Control and Prevention, Shanghai, China, 3) Chenggong Hospital
affiliated to Xiamen University, Xiamen, China, and 4) MGGen, Northern
Arizona University, Flagstaff, AZ, USA
Abstract
We report here on the first identification of Shigella flexneri sub-
serotype 1c in China. We also report the emergence of resistance
to ciprofloxacin and third-generation cephalosporins in this sub-
serotype 1c for the first time. Isolates of seven strains circulating
in China yielded three new sequence types and seven pulsed-field
gel electrophoresis patterns, thus demonstrating the existence of
high genetic diversity within the isolates. Overall, the seven iso-
lates showed reduced susceptibility to ciprofloxacin; one isolate
was ciprofloxacin resistant, whilst another developed resistance
to ciprofloxacin, norfloxacin, cefotaxime and ceftriaxone.
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Shigellosis is one of the major diarrhoeal diseases in develop-
ing countries and is a significant public health burden. It has
an annual incidence of 160 million cases, resulting in more
than a million deaths worldwide [1]. In China, shigellosis was
one of the top four notifiable infectious diseases from 2005
to 2008, with nearly half a million cases reported each year
[2]. Shigella flexneri is the major cause of endemic shigellosis
in developing countries, including China [3,4]. At present,
there are at least 15 recognized S. flexneri subserotypes and
several provisional and new subserotypes; the 1c subsero-
type is a recent addition. The 1c subserotype is prevalent in
several countries, including Bangladesh, Egypt, Indonesia,
Pakistan and Vietnam [5–8].
Here for the first time we report the identification of
S. flexneri subserotype 1c in China. We identified a total of
seven subserotype 1c isolates from routine surveillance of
263 Shigella isolates. The isolates were recovered from
10 021 stool samples collected from diarrhoeal patients in
the eastern, western, southern, northern and central regions
of China between 2008 and 2010. These isolates were con-
firmed by conventional biochemical testing, API 20E strips
(BioMerieux Vitek, Marcy-l’Etoile, France) and serotyping.
Serotyping was performed using slide agglutination with two
commonly used serotyping kits, one of which is a commer-
cially available antisera kit (Denka Seiken, Tokyo, Japan),
whilst another consists of a panel of monoclonal antibodies
against S. flexneri (MASF) (Reagensia AB, Stockholm, Swe-
den). Three isolates were detected first in Shanghai in China
in 2008, followed by another one in 2009 and two others in
2010; an additional one was isolated in Beijing in 2009
(Table 1). Epidemiological investigations raised the possibility
that these isolates were indicative of the subserotype 1c cir-
culating in China as the corresponding patients all denied a
history of travelling abroad or contact with foreigners from
an endemic area of shigellosis.
Antibiotic susceptibility testing of the isolates was con-
ducted using the disc diffusion method with commercially
available antibiotic discs (Oxoid, Basingstoke, UK), accord-
ing to Clinical and Laboratory Standards Institute (CLSI)
guidelines. The minimum inhibitory concentrations (MICs)
of nalidixic acid, ciprofloxacin, norfloxacin, cefotaxime and
ceftriaxone were determined using the E-test method (AB
Biodisk, Solna, Sweden). To understand the underlying
mechanism conferring resistance to fluoroquinolones and
third-generation cephalosporins, PCR assays [9–11] were
used to detect the quinolone resistance-determining regions
(QRDRs) of the gyrA, gyrB, parC and parE genes and the
plasmid-mediated quinolone resistance (PMQR) determi-
nants, including the qnrA, qnrB, qnrS and aac(6¢)-1b-cr genes.
We also screened for the presence of b-lactamase genes,
such as blaSHV, blaTEM and blaCTX-M. Multilocus
sequence typing (MLST) described in the EcMLST website
(http://www.shigatox.net/ecmlst/cgi-bin/index) and pulsed-
field gel electrophoresis (PFGE) using the PulseNet stan-
dardized protocol [12] were performed to determine the
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genetic relatedness among the isolates of subserotype 1c
and other subserotypes.
The subserotype 1c isolates from Bangladesh and Vietnam
were found to belong to the same sequence type (ST7-50)
based on analysis of seven housekeeping genes [7]. In this
study, we designated all of the subserotype 1c isolates, with
one exception, as ST7-52, prior to subdivision into three
novel STs based on 15 genes (Fig. 1). Of these, ST15-105
contained a new allele, rpoS-63. This result suggested to us
that the Chinese subserotype 1c isolates might be genetically
distinct from those originating from the endemic regions.
The seven subserotype 1c isolates comprised seven different
banding patterns, as shown by PFGE analysis (Fig. 1). Two
subserotype 1c isolates and five subserotype 1a isolates
belonging to ST15-100 formed a single cluster (cluster A).
Four subserotype 2a isolates and two subserotype 1c iso-
TABLE 1. Details of the Shigella flexneri subserotype 1c isolates recovered from diarrhoeal patients in China
Isolate Region Year
MICs (lg/mL)a
Additional resistance
Amino acid change
PMQR
determinant CTX-MNA CI NX CT TX GyrA ParC
Shig0127 Shanghai 2010 >256 8 16 >256 >256 AM, SAM, AMC, TE, C, SXT,
LEV
Ser83 ﬁ Leu,
Asp87 ﬁ Gly
Ser80 ﬁ Ile – CTX-M-57
Shig0125 Shanghai 2008 >256 4 16 0.06 0.06 AM, SAM, AMC, TE, C, SXT,
LEV
Ser83 ﬁ Leu,
Asp87 ﬁ Gly
Ser80 ﬁ Ile – –
Shig0128 Shanghai 2010 >256 2 12 0.03 0.06 AM, SAM, AMC, TE, C, SXT,
LEV
Ser83 ﬁ Leu Ser80 ﬁ Ile aac(6¢)-Ib-cr –
Shig0129 Shanghai 2009 >256 2 12 0.06 0.06 AM, SAM, AMC, TE, C, SXT Ser83 ﬁ Leu Ser80 ﬁ Ile aac(6¢)-Ib-cr –
Shig0126 Shanghai 2008 >256 0.50 2 0.03 0.03 AM, SAM, AMC, TE, C, SXT Ser83 ﬁ Leu Ser80 ﬁ Ile – –
Shig0130 Shanghai 2008 >256 0.50 4 0.06 0.06 AM, SAM, AMC, TE, C Ser83 ﬁ Leu Ser80 ﬁ Ile – –
Shig0124 Beijing 2009 >256 0.50 4 0.06 0.06 AM, SAM, AMC, TE, C, SXT Ser83 ﬁ Leu Ser80 ﬁ Ile – –
aNA, nalidixic acid.
CI, ciprofloxacin; NX, norfloxacin; CT, cefotaxime; TX, ceftriaxone; AM, ampicillin; SAM, ampicillin/sulbactam; AMC, amoxicillin/clavulanic acid; TE, tetracycline; C, chloram-
phenicol; SXT, trimethoprim/sulphamethoxazole; LEV, levofloxacin.
FIG. 1. Pulsed-field gel electrophoresis (PFGE) analysis of Shigella flexneri isolates. The dendrogram based on the unweighted pair group method
with arithmetic mean and Dice coefficient shows the level of genetic relatedness among the isolates of subserotype 1c and other subserotypes.
Three clusters are obtained according to 80% similarity. The species, serotypes, regions and ST of the strains are shown.
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lates belonging to ST15-100, as well as two isolates identified
as ST15-105, clustered together (Cluster B). Cluster C was
shared by one subserotype 1c isolate and nine subserotype
1b isolates belonging to ST15-104. The above results indi-
cated that Chinese subserotype 1c isolates are genetically
diverse and may originate from different ancestors by sero-
type switching [4,7].
So far, none of the subserotype 1c isolates from S. flexneri
endemic regions have been found to be resistant to fluor-
oquinolones or third-generation cephalosporins [13,14]. Sur-
prisingly, in this study, we found the emergence of resistance
to fluoroquinolones and third-generation cephalosporins
among Chinese S. flexneri subserotype 1c isolates. All the
subserotype 1c isolates tested were resistant to ampicillin,
ampicillin/sulbactam, amoxicillin/clavulanic acid, tetracycline,
chloramphenicol and nalidixic acid; 85.7% were also resistant
to trimethoprim/sulphamethoxazole (Table 1). Furthermore,
five isolates showed reduced susceptibility to ciprofloxacin
(MICs, 0.5–2 lg/mL). All five isolates had double mutations
(Ser83 ﬁ Leu in gyrA, Ser80 ﬁ Ile in parC); however, two
isolates also contained the aac(6¢)-Ib-cr gene. Additionally,
one of the isolates developed ciprofloxacin resistance (MIC,
4 lg/mL), and DNA sequence analysis showed that this iso-
late had a triple mutation genotype (i.e. two mutations in
gyrA (Ser83 ﬁ Leu, Asp87 ﬁ Gly) and one in parC
(Ser80 ﬁ Ile)). Of concern is the fact that one isolate devel-
oped resistance to 12 of the 14 antibiotics tested, including
norfloxacin (MIC, 16 lg/mL), ciprofloxacin (MIC, 8 lg/mL),
cefotaxime (MIC, >256 lg/mL) and ceftriaxone (MIC,
>256 lg/mL); this particular isolate had the same triple muta-
tion genotype, but also possessed the blaCTX-M-57 gene
(Table 1). To our knowledge, this is the first time that the
gene encoding the CTX-M-57 enzyme has been detected in
Shigella, and also the first report of subserotype 1c exhibiting
resistance to both ciprofloxacin and ceftriaxone. Ciprofloxa-
cin is currently the first-line antibiotic recommended by the
World Health Organization for the treatment of shigellosis
[15]. Third-generation cephalosporins are considered as
alternative drugs for shigellosis treatment [15]. Hence, emer-
gence of resistance to fluoroquinolones and third-generation
cephalosporins will pose a great challenge for the effective
treatment of shigellosis.
In conclusion, this is the first time that the S. flexneri subser-
otype 1c has been reported in China, and the first report on
the emergence of resistance to ciprofloxacin and third-genera-
tion cephalosporins in this subserotype. With increasing glob-
alization, the potentially widespread dissemination of these
strains poses a major threat to public health, not only in China,
but also the rest of the world. Continuous surveillance will be
needed to determine the prevalence and dissemination of this
subserotype, as well as its potential to develop resistance to
antimicrobial agents.
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